A recent study indicated that improvement of sleep quality is beneficial in reducing blood pressure and lowering cardiometabolic risk.

The key results were as follows:

• At the 24-month follow-up, both groups showed improvements in cardio-metabolic risk factors.
• The systolic blood pressure was reduced by 11mmHg in the intervention group and 4mmHg in the usual care group.
• Participants in the intervention group additionally had a reduction in diastolic blood pressure, increase in high-density lipoprotein (good cholesterol) and decrease in triglyceride levels from baseline to 24 months
• An increase in sleep efficiency was independently associated with lower systolic blood pressure.
• An increase in total sleep time was associated with lower low-density lipoprotein (bad cholesterol) levels at 24 months.